• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过脂质纳米球提高雷公藤红素的口服生物利用度:制备、表征及吸收评价

Enhancement of oral bioavailability of tripterine through lipid nanospheres: preparation, characterization, and absorption evaluation.

作者信息

Zhang Xingwang, Zhang Tianpeng, Zhou Xiaotong, Liu Hongming, Sun Hua, Ma Zhiguo, Wu Baojian

机构信息

College of Pharmacy, Jinan University, Guangzhou, China.

出版信息

J Pharm Sci. 2014 Jun;103(6):1711-9. doi: 10.1002/jps.23967. Epub 2014 Apr 2.

DOI:10.1002/jps.23967
PMID:24700417
Abstract

Oral delivery of anticancer drugs remains challenging because of limited water-solubility and/or poor permeability. Here, we aimed to enhance the oral bioavailability of tripterine (TRI, a plant-derived anticancer compound) using lipid nanospheres (LNs) and to determine the mechanisms of oral absorption. TRI-loaded LNs (TRI-LNs) were prepared by rapid dispersion of an ethanol mixture of TRI, lecithin, sodium oleate, and soybean oil into water. The obtained LNs were 150 nm in size with a high value of entrapment efficiency (99.95%). TRI-LNs were fairly stable and the drug release was negligible (<0.2%) in simulated physiological fluid. The pharmacokinetic results showed that LNs significantly enhanced the oral bioavailability of TRI with a relative bioavailability of 224.88% (TRI suspensions was used as a reference). The mechanistic studies demonstrated that improved intestinal permeability and post-enterocyte lymphatic transport were mainly responsible for the enhanced oral absorption. Our findings suggested that LNs may be a viable oral carrier for poorly bioavailable drugs.

摘要

由于水溶性有限和/或渗透性差,口服抗癌药物仍然具有挑战性。在此,我们旨在使用脂质纳米球(LNs)提高雷公藤红素(TRI,一种植物来源的抗癌化合物)的口服生物利用度,并确定口服吸收的机制。通过将TRI、卵磷脂、油酸钠和大豆油的乙醇混合物快速分散到水中来制备载TRI的LNs(TRI-LNs)。所获得的LNs尺寸为150 nm,包封率高(99.95%)。TRI-LNs相当稳定,在模拟生理流体中的药物释放可忽略不计(<0.2%)。药代动力学结果表明,LNs显著提高了TRI的口服生物利用度,相对生物利用度为224.88%(以TRI悬浮液作为对照)。机制研究表明,肠道通透性的改善和肠细胞后淋巴转运是口服吸收增强的主要原因。我们的研究结果表明,LNs可能是生物利用度差的药物的一种可行的口服载体。

相似文献

1
Enhancement of oral bioavailability of tripterine through lipid nanospheres: preparation, characterization, and absorption evaluation.通过脂质纳米球提高雷公藤红素的口服生物利用度:制备、表征及吸收评价
J Pharm Sci. 2014 Jun;103(6):1711-9. doi: 10.1002/jps.23967. Epub 2014 Apr 2.
2
Enhanced bioavailability of tripterine through lipid nanoparticles using broccoli-derived lipids as a carrier material.以西兰花衍生脂质为载体材料的脂质纳米粒提高了雷公藤红素的生物利用度。
Int J Pharm. 2015 Nov 30;495(2):948-55. doi: 10.1016/j.ijpharm.2015.10.011. Epub 2015 Oct 20.
3
Nanosuspensions Containing Oridonin/HP-β-Cyclodextrin Inclusion Complexes for Oral Bioavailability Enhancement via Improved Dissolution and Permeability.含有冬凌草甲素/羟丙基-β-环糊精包合物的纳米混悬剂,通过改善溶解和渗透性提高口服生物利用度。
AAPS PharmSciTech. 2016 Apr;17(2):400-8. doi: 10.1208/s12249-015-0363-4. Epub 2015 Jul 18.
4
Preparation of tripterine nanostructured lipid carriers and their absorption in rat intestine.雷公藤红素纳米结构脂质载体的制备及其在大鼠肠道中的吸收
Pharmazie. 2012 Apr;67(4):304-10.
5
Nanostructured lipid carriers versus microemulsions for delivery of the poorly water-soluble drug luteolin.纳米结构脂质载体与微乳液用于递送疏水性差的药物木樨草素。
Int J Pharm. 2014 Dec 10;476(1-2):169-77. doi: 10.1016/j.ijpharm.2014.09.052. Epub 2014 Oct 1.
6
Nanostructured lipid carriers used for oral delivery of oridonin: an effect of ligand modification on absorption.用于冬凌草甲素口服递送的纳米结构脂质载体:配体修饰对吸收的影响
Int J Pharm. 2015 Feb 20;479(2):391-8. doi: 10.1016/j.ijpharm.2014.12.068. Epub 2014 Dec 30.
7
In-situ single pass intestinal permeability and pharmacokinetic study of developed Lumefantrine loaded solid lipid nanoparticles.已开发的载有卤泛群的固体脂质纳米粒的原位单次肠道通透性和药代动力学研究
Int J Pharm. 2017 Jan 10;516(1-2):120-130. doi: 10.1016/j.ijpharm.2016.10.064. Epub 2016 Oct 29.
8
Candesartan cilexetil loaded solid lipid nanoparticles for oral delivery: characterization, pharmacokinetic and pharmacodynamic evaluation.用于口服给药的坎地沙坦酯固体脂质纳米粒:表征、药代动力学和药效学评价
Drug Deliv. 2016;23(2):395-404. doi: 10.3109/10717544.2014.914986. Epub 2014 May 28.
9
A study to enhance the oral bioavailability of s-adenosyl-l-methionine (SAMe): SLN and SLN nanocomposite particles.一项提高 S-腺苷甲硫氨酸(SAMe)口服生物利用度的研究:固体脂质纳米粒(SLN)和 SLN 纳米复合粒子。
Chem Phys Lipids. 2021 Jul;237:105086. doi: 10.1016/j.chemphyslip.2021.105086. Epub 2021 Apr 27.
10
Effects of PEGylated lipid nanoparticles on the oral absorption of one BCS II drug: a mechanistic investigation.聚乙二醇化脂质纳米粒对一种BCS II类药物口服吸收的影响:一项机制研究。
Int J Nanomedicine. 2014 Nov 26;9:5503-14. doi: 10.2147/IJN.S73340. eCollection 2014.

引用本文的文献

1
From Physicochemical Constraints to Clinical Prospects of Celastrol: Challenges and Nano Delivery Strategies.从雷公藤红素的物理化学限制到临床前景:挑战与纳米递送策略
Int J Nanomedicine. 2025 Sep 5;20:10907-10931. doi: 10.2147/IJN.S539586. eCollection 2025.
2
Celastrol targets CKB-mediated futile creatine cycle in human brown adipocytes thermogenesis.雷公藤红素作用于人类棕色脂肪细胞产热过程中由肌酸激酶B介导的无效肌酸循环。
Metabol Open. 2025 Mar 20;26:100359. doi: 10.1016/j.metop.2025.100359. eCollection 2025 Jun.
3
Bioactive Compounds Formulated in Phytosomes Administered as Complementary Therapy for Metabolic Disorders.
以植物药囊泡形式配制的生物活性化合物作为代谢紊乱的辅助疗法。
Int J Mol Sci. 2024 Apr 9;25(8):4162. doi: 10.3390/ijms25084162.
4
Triterpenes Drug Delivery Systems, a Modern Approach for Arthritis Targeted Therapy.三萜类药物递送系统,一种用于关节炎靶向治疗的现代方法。
Pharmaceuticals (Basel). 2023 Dec 28;17(1):54. doi: 10.3390/ph17010054.
5
Selenized Polymer-Lipid Hybrid Nanoparticles for Oral Delivery of Tripterine with Ameliorative Oral Anti-Enteritis Activity and Bioavailability.用于雷公藤红素口服递送的硒化聚合物-脂质杂化纳米颗粒,具有改善的口服抗肠炎活性和生物利用度。
Pharmaceutics. 2023 Mar 2;15(3):821. doi: 10.3390/pharmaceutics15030821.
6
An intra-articular injectable phospholipids-based gel for the treatment of rheumatoid arthritis.一种用于治疗类风湿性关节炎的关节内注射用磷脂基凝胶。
Asian J Pharm Sci. 2023 Jan;18(1):100777. doi: 10.1016/j.ajps.2023.100777. Epub 2023 Jan 18.
7
Bioavailability Enhancement Techniques for Poorly Aqueous Soluble Drugs and Therapeutics.难溶性药物和治疗剂的生物利用度提高技术
Biomedicines. 2022 Aug 23;10(9):2055. doi: 10.3390/biomedicines10092055.
8
Celastrol: A Promising Agent Fighting against Cardiovascular Diseases.雷公藤红素:一种对抗心血管疾病的有前景的药物。
Antioxidants (Basel). 2022 Aug 18;11(8):1597. doi: 10.3390/antiox11081597.
9
Exploring the Potential of Natural Product-Based Nanomedicine for Maintaining Oral Health.探索基于天然产物的纳米医学在维护口腔健康方面的潜力。
Molecules. 2022 Mar 7;27(5):1725. doi: 10.3390/molecules27051725.
10
Celastrol-conjugated chitosan oligosaccharide for the treatment of pancreatic cancer.姜黄素结合壳寡糖用于胰腺癌治疗。
Drug Deliv. 2022 Dec;29(1):89-98. doi: 10.1080/10717544.2021.2018521.